Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 170 for “"PK/PD"”.
-
PK/PD Modeling of Targeted Protein Degraders
Targeted protein degradation (TPD) promises to bring about the next paradigm shift in therapeutic modalities by eliminating disease related proteins deemed undruggable for conventional small molecule inhibitors. Despite the ap-proach recently coming of age, hallmarked by the first compounds …
-
Development of Combination Therapies of Pazopanib Through a PK/PD Approach
… by nilotinib, suggesting that the combined PK/PD approach developed here can be used to identify clinically useful novel TKI combinations to enhance intracellular concentrations of a targeted TKI and improve its therapeutic efficacy. The role of P-gp in the resistance development and …
-
DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS
… [PG] dimension to any pharmacokinetic [PK] and pharmacodynamic [PD] analysis. The goal of this project was to characterize the PK/PD properties of gefitinib in tumors and then apply these results to design rational drug design regimens, and provide a foundation for future studies with …
-
Semiparametric mixed-effects analysis on PK/PD models using differential equations
This dissertation consists of three papers written on semiparametric mixed-effects analysis in the presence of structural model misspecification. In the first paper, we develop a new semiparametric modeling approach to address potential structural model misspecification. Specifically, we use a set …
-
New pharmacokinetic and PK/PD drug development methodologies for cutaneous leishmaniasis
… the infected skin lesions (pharmacokinetics, PK), (ii) the ability to kill the causative Leishmania parasites (pharmacodynamics, PD) and (iii) the interaction between PK and PD (PK/PD) parameters. In chapter 3.1, the limitations of the current in vitro models to predict in vivo drug activity …
-
Modelagem pk/pd das fluoroquinolonas levofloxacino e moxifloxacino visando o tratamento da prostatite
… um modelo farmacocinético/farmacodinâmico (PK/PD) para descrever o efeito bactericida in vitro das fluoroquinolonas levofloxacino (LEV) e moxifloxacino (MXF)contra Escherichia coli, baseando-se em dados in vivo de concentração livre prostática. Métodos: Ratos Wistar machos foram utilizados …
-
Modelagem farmacocinética/farmacodinâmica (PK/PD) da quetiapina nanoencapsulada em modelo animal de esquizofrenia
… no transporte de fármacos antipsicóticos (APD) para o sistema nervoso central (SNC). Com base na hipótese que a redução na penetração cerebral de fármacos para o SNC em pacientes com SCZ poderia estar associada à resistência à farmacoterapia foram desenvolvidas nanocápsulas poliméricas de …
-
Diethylstilbestrol Nanosuspensions for Prostate Cancer: Subcutaneous Sustained Release Formulations and Pre-clinical PK/PD Evaluations
Prostate cancer is the most common type of cancer and the second leading cause of cancer related deaths in men in the United States. According to the National Cancer Institute (NCI), 238,590 new cases with deaths of 29,720 from prostate cancer have been estimated for 2013. Diethylstilbestrol (DES) …
-
Developing predictive PK/PD models to optimise dosing regimens for antibiotics for gram-negative infections
Pharmacokinetic/pharmacodynamic (PK/PD) modelling and simulation are increasingly recognised as powerful tools for optimising antibiotic dosing. This approach plays a critical role in enhancing the effectiveness of the older generation of antibiotics, preserving the efficacy of new generation …
-
Impacts of Spinal Cord Injury and Formulation on Riluzole Pharmacokinetics and Pharmacokinetics/Pharmacodynamics (PK/PD) Correlation
… for this therapy. Therefore, pharmacokinetic (PK) and pharmacodynamic (PD) study of Riluzole is of great importance for us to understand its toxicity and efficacy in acute SCI patients. We hypothesize that spinal cord injury and formulation/administration alteration would affect the …
-
PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODELLING: APPROACHES TO ASSESS THE INTERACTIONS BETWEEN TUBERCULOSIS AND DIABETES OR HIV
… of rifampin on the pharmacokinetics (PK) of tenofovir alafenamide, an anti-retroviral drug known to have higher stability and a better safety profile than the standard formulation, tenofovir disoproxil fumarate. Chapter-3 is a pharmacology-focused sub-study nested in a longitudinal …
-
Development and validation of LC-MS/MS methods to determine PK/PD parameters of anti-infectives
… which might be a starting point for further PK/PD investigations. The PK/PD theory is a very helpful tool for prediction of the efficacy of given drugs against certain micro-organisms. Depending on the pharmacodynamic processes, e. g. the mode of action, three classes of drugs have been …
-
A Pharmacokinetics and Pharmacodynamics (PK/PD) Guided Approach to Lead Optimization of Nitrofuranylamide Anti-Tuberculosis Agents
… iterative pharmacokinetics and pharmacodynamics (PK/PD) guided approach would facilitate the optimization of nitrofuranylamide lead compounds suitable for further development. First, we examined the biopharmaceutic properties and preclinical PK of nitrofuranylamide lead compounds. The first tested …
-
PRUDENT USE OF FLUOROQUINOLONES IN AVIAN SPECIES: PHARMACOKINETICS OF FLUMEQUINE AND ENROFLOXACIN FOR PK/PD MODELLING IN TURKEY.
… common zoonotic avian pathogen. Pharmacokinetic(PK)/pharmacodynamics (PD) models are the best tool in order to select optimal dosage regimen. To confirm dosages used at farms and allow the integration of PK/PD data, the plasma concentrations in blood from healthy animals collected during …
-
Modelagem farmacocinética/farmacodinâmica (PK/PD) para caracterização do efeito do ciprofloxacino em infecções com biofilmes de Pseudomonas aeruginosa
… um modelo farmacocinético/farmacodinâmico (PK/PD) para descrever o efeito do ciprofloxacino (CIP) na presença de biofilmes de Pseudomonas aeruginosa (ATCC 27853), visto que a modelagem PK/PD de antimicrobianos é uma ferramenta útil na escolha de regimes posológicos que atinjam o efeito …
-
Prediction of In-Vivo Antimuscarinic Activity (AMA) by In-Vitro Receptor Binding Assessment and PK/PD Modeling For Prototypical Drugs
Purpose: To establish a tool, termed as antimuscarinic activity (AMA), to predict the incidence of antimuscarinic adverse events (AMAEs).Methods: A literature review, focused on drugs having off-target interaction with muscarinic receptors, was performed. Prototypical drugs olanzapine, …
-
Impacts of Bariatric Surgery on Clinical Pharmacokinetics/ Pharmacodynamics (PK/PD) of Metformin and Statins among Caucasian, African and Hispanic American Populations
… and physiological changes may also alter the PK, PD, and PK/PD relationships of Statins and Metformin in the obese population. This dissertation evaluated longitudinal clinical outcomes and RYGB effects on statins and metformin exposure and response among Caucasian, African American, Hispanic, …
-
Of Mice and Women: Understanding Pregnancy-Induced Changes in Glyburide PK/PD for the Improved Management of Gestational Diabetes Mellitus (GDM)
Pregnancy-induced changes in drug PK is explained by changes in physiology and expression of metabolic enzymes and transporters. We determined mRNA expression of enzymes and transporters in the maternal liver, kidney, small intestine, and placenta of pregnant mice by microarray analysis. A full …
-
Pharmacokinetics/Pharmacodynamics (PK/PD) of Oral Diethylstilbestrol (DES) in Recurrent Prostate Cancer Patients and of Oral Dissolving Film (ODF)-DES in Rats
Prostate cancer is the most diagnosed non-skin cancer and the second leading cause of cancer related death in men in the United States. According to the National Cancer Institute (NCI), an estimated 217,730 men were diagnosed with prostate cancer in 2010 and 32,050 died from the disease. For …
-
Development of practice-oriented LC-MS/MS methods for the determination of important drugs and their application for building PK/PD concepts
In this thesis eight robust and reliable LC-MS/MS methods were developed and validated to analyze atorvastatin, clopidogrel, furosemide, itraconazole, loratadine, naproxen, nisoldipine and sunitinib in human plasma. The active metabolites 2-hydroxyatorvastatin, 4-hydroxyatorvastatin, …
Page 1 of 9